Award
NIH Reporter #5U01CA286811-04
Assessing benefits and harms of cannabis use in patients treated with immunotherapy for cancer: a prospective cohort study
Recipient
State University of New York at Buffalo, Amherst, NY
Award Amount
$632,414.00
Ceiling
$632,414.00
Awarded
August 11, 2026
Identifier
5U01CA286811-04
A NIH-funded prospective cohort study to assess the benefits and harms of cannabis use in cancer patients undergoing immunotherapy, focusing on patient outcomes and immune markers.
Description
This project aims to evaluate the long-term benefits and harms of cannabis use among cancer patients treated with immune checkpoint inhibitors (ICIs). It involves a 12-month prospective cohort study with 450 participants across multiple sites, assessing cannabis use, patient-reported outcomes, and immunological markers.